Medtronic Financial Statements
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medtronic revenue and earnings
In fiscal 2026, Medtronic generated $36.36 billion in revenue, up 8.4% from fiscal 2025, its 3rd consecutive year of revenue growth. Net income was $4.80 billion (+3.0% year over year), for a net margin of 13.2% versus a median of 12.0% in the prior 5 years. Gross margin was 65.0% (down from 65.3%) and operating margin 17.8%.
Diluted earnings per share came in at $3.73, up from $3.61. Over the last 5 fiscal years, MDT's revenue has grown at a 3.8% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Medtronic income statement (annual)
| Fiscal year (USD) | FY 20262026-04-24 | FY 20252025-04-25 | FY 20242024-04-26 | FY 20232023-04-28 | FY 20222022-04-29 | FY 20212021-04-30 | FY 20202020-04-24 | FY 20192019-04-26 | FY 20182018-04-27 | FY 20172017-04-28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.36B | 33.54B | 32.36B | 31.23B | 31.69B | 30.12B | 28.91B | 30.56B | 29.95B | 29.71B |
| Revenue growth (YoY) | +8.43% | +3.62% | +3.64% | -1.45% | +5.21% | +4.16% | -5.38% | +2.02% | +0.82% | +3.04% |
| Cost of Revenue | 12.72B | 11.63B | 11.22B | 10.72B | 10.14B | 10.48B | 9.42B | 9.15B | 9.07B | 9.29B |
| Gross Profit | 23.64B | 21.91B | 21.15B | 20.51B | 21.54B | 19.63B | 19.49B | 21.40B | 20.90B | 20.42B |
| Operating Expenses | 17.18B | 15.95B | 16.00B | 15.02B | 15.79B | 15.15B | 14.70B | 15.13B | 14.26B | 15.04B |
| Research & Development | 2.87B | 2.73B | 2.73B | 2.70B | 2.75B | 2.49B | 2.33B | 2.33B | 2.26B | 2.19B |
| Selling, General & Admin | 11.78B | 10.85B | 10.74B | 10.41B | 10.29B | 10.15B | 10.11B | 10.42B | 10.24B | 10.02B |
| Operating Income | 6.47B | 5.96B | 5.14B | 5.49B | 5.75B | 4.48B | 4.79B | 6.27B | 6.64B | 5.38B |
| Interest Expense | 715.00M | 729.00M | 719.00M | 636.00M | 553.00M | 925.00M | 1.09B | 1.44B | 1.15B | 1.09B |
| Other Income (Expense) | 384.00M | 402.00M | 412.00M | 515.00M | 318.00M | 336.00M | 356.00M | 373.00M | -505.00M | -222.00M |
| Pretax Income | 6.14B | 5.63B | 4.84B | 5.36B | 5.52B | 3.90B | 4.05B | 5.20B | 5.67B | 4.60B |
| Income Tax | 1.30B | 936.00M | 1.13B | 1.58B | 456.00M | 265.00M | -751.00M | 547.00M | 2.58B | 578.00M |
| Net Income | 4.80B | 4.66B | 3.68B | 3.76B | 5.04B | 3.61B | 4.79B | 4.63B | 3.10B | 4.03B |
| Net Income growth (YoY) | +2.98% | +26.82% | -2.18% | -25.42% | +39.74% | -24.70% | +3.41% | +49.19% | -22.94% | +13.85% |
| EPS (Basic) | 3.75 | 3.63 | 2.77 | 2.83 | 3.75 | 2.68 | 3.57 | 3.44 | 2.29 | 2.92 |
| EPS (Diluted) | 3.73 | 3.61 | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 | 3.41 | 2.27 | 2.89 |
| Shares Outstanding (Basic) | 1.28B | 1.29B | 1.33B | 1.33B | 1.34B | 1.34B | 1.34B | 1.35B | 1.36B | 1.38B |
| Shares Outstanding (Diluted) | 1.29B | 1.29B | 1.33B | 1.33B | 1.35B | 1.35B | 1.35B | 1.36B | 1.37B | 1.39B |
| EBITDA | 9.43B | 8.82B | 7.79B | 8.18B | 8.46B | 7.19B | 7.45B | 8.93B | 9.28B | 8.30B |
| Gross Margin | 65.02% | 65.32% | 65.34% | 65.67% | 67.98% | 65.19% | 67.41% | 70.04% | 69.77% | 68.73% |
| Operating Margin | 17.78% | 17.76% | 15.89% | 17.56% | 18.15% | 14.89% | 16.57% | 20.51% | 22.17% | 18.12% |
| Net Margin | 13.20% | 13.90% | 11.36% | 12.03% | 15.90% | 11.97% | 16.56% | 15.16% | 10.36% | 13.56% |
This table shows 10 annual periods of Medtronic's income statement, from FY 2026 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MDT's reporting calendar. What is a income statement?